These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 20470354)
1. Can a microarray implicate human genes in post-transplant lymphoproliferative disorders? Davies M; Rowe D Pediatr Transplant; 2009 Dec; 13(8):944-7. PubMed ID: 20470354 [No Abstract] [Full Text] [Related]
2. Gene expression using microarrays in transplant recipients at risk of EBV lymphoproliferation after organ transplantation: preliminary proof-of-concept. Allen U; Barton M; Beyene J; Hu P; Khodai-Booran N; Hébert D; Dipchand A; Ng V; Solomon M; Grant D; Fecteau A; Ngan B; Read S; Zielenska M; Weitzman S Pediatr Transplant; 2009 Dec; 13(8):990-8. PubMed ID: 19735433 [TBL] [Abstract][Full Text] [Related]
3. Proteomics analysis in post-transplant lymphoproliferative disorders. Alsayed Y; Leleu X; Leontovich A; Oton AB; Melhem M; George D; Ghobrial IM Eur J Haematol; 2008 Oct; 81(4):298-303. PubMed ID: 18573174 [TBL] [Abstract][Full Text] [Related]
5. Associations among Epstein-Barr virus subtypes, human leukocyte antigen class I alleles, and the development of posttransplantation lymphoproliferative disorder in bone marrow transplant recipients. Görzer I; Puchhammer-Stöckl E; van Esser JW; Niesters HG; Cornelissen JJ Clin Infect Dis; 2007 Mar; 44(5):693-5. PubMed ID: 17278061 [TBL] [Abstract][Full Text] [Related]
6. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection? Burra P; Buda A; Livi U; Rigotti P; Zanus G; Calabrese F; Caforio A; Menin C; Canova D; Farinati F; Luciana Aversa SM Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder. Bar-Natan M; Nagler A Isr Med Assoc J; 2006 Mar; 8(3):205-7. PubMed ID: 16599060 [No Abstract] [Full Text] [Related]
8. Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes. Bräuninger A; Spieker T; Mottok A; Baur AS; Küppers R; Hansmann ML Eur J Immunol; 2003 Jun; 33(6):1593-602. PubMed ID: 12778477 [TBL] [Abstract][Full Text] [Related]
9. Central nervous system post-transplant lymphoproliferative disorder despite negative serum and spinal fluid Epstein-Barr virus DNA PCR. Hamadani M; Martin LK; Benson DM; Copelan EA; Devine SM; Hofmeister CC Bone Marrow Transplant; 2007 Feb; 39(4):249-51. PubMed ID: 17290281 [No Abstract] [Full Text] [Related]
11. Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders. Oudejans JJ; Jiwa M; van den Brule AJ; Grässer FA; Horstman A; Vos W; Kluin PM; van der Valk P; Walboomers JM; Meijer CJ Am J Pathol; 1995 Oct; 147(4):923-33. PubMed ID: 7573368 [TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients. Capello D; Rasi S; Oreste P; Veronese S; Cerri M; Ravelli E; Rossi D; Minola E; Colosimo A; Gambacorta M; Muti G; Morra E; Gaidano G J Pathol; 2009 Aug; 218(4):478-86. PubMed ID: 19391128 [TBL] [Abstract][Full Text] [Related]